Trade LXRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lexicon Pharmaceuticals, Inc. (LXRX) is trading at US$1.74, down 4.40% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$1.02B. Over the past 52 weeks, LXRX has traded between US$1.10 and US$2.68. On Syfe you can trade LXRX with $0 commission and add it to your watchlist.
| Previous close | US$1.82 |
|---|---|
| Market cap | US$1.02B |
| 52-week range | US$1.10 – US$2.68 |
| Volume | 2.66M |
| Exchange | US |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Year: 2000
Lexicon Pharmaceuticals Gets $10 Million Novo Nordisk Milestone Payment for LX9851
Aug 24, 1:01 PM · MT Newswires
--Earnings Flash (LXRX) Lexicon Pharmaceuticals Posts Q2 Loss $0.07 a Share, vs. FactSet Est of $0.05 Loss
Aug 6, 11:56 AM · MT Newswires
-- Earnings Flash (LXRX) Lexicon Pharmaceuticals, Inc. Reports Q2 Revenue $692,000, vs. FactSet Est of $4.0M
Aug 6, 11:37 AM · MT Newswires
Lexicon Pharmaceuticals, Inc. (LXRX) stock is trading at US$1.74, -4.40% from the previous close of US$1.82.
The market cap for Lexicon Pharmaceuticals, Inc. (LXRX) stock is approximately US$1.02B.
The 52-week high for Lexicon Pharmaceuticals, Inc. (LXRX) stock is US$2.68.
The 52-week low for Lexicon Pharmaceuticals, Inc. (LXRX) stock is US$1.10.
Lexicon Pharmaceuticals, Inc. (LXRX) does not currently pay a dividend.
Stay on top of LXRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
